ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

WHO director general Tedros Adhanom Ghebreyesus says this new drug—which only needs to be injected twice a year—is the next ...

Researchers at Washington University School of Medicine in St. Louis have revealed the structure of a key protein involved in ...

In the ongoing fight against HIV, scientists have taken a new step toward long-term control of the virus. Researchers have ...

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah biochemist whose discoveries helped make the drug happen worries government cuts ...

Latently infected T cells reside in B-cell follicles (BCFs), a lymphoid tissue structure where CD4+ T cells play an important role in B cell development. BCFs exclude CD8+ T cells that can recognize ...

Because viruses have to hijack someone else’s cell to replicate, they’ve gotten very good at it—inventing all sorts of tricks. A new study from two University of Chicago scientists has revealed how ...

Two-photon fluorescence lifetime imaging microscopy of NADH metabolism in HIV-1 infected cells and tissues Greg A. Snyder 1,2 Sameer Kumar 1 George K. Lewis 1,2 Krishanu Ray 1,3* ...

When encapsidated in budding HIV-1 virions, APOBEC3G (A3G) suppresses viral amplification by modifying the viral genome after reverse transcription in infected cells (left).

Considerable recent research has emerged regarding NK cells in the areas of immune checkpoints, negative regulation, antibody-dependent cell-mediated cytotoxicity and HIV reservoirs during HIV ...